A. John Murray, Ph.D.

Dr. Murray's practice includes patent prosecution, interference, opinions and litigation, primarily in the areas of biotechnology, medical devices and in vitro diagnostics. He is experienced in writing and prosecuting U.S. and international patent applications relating to diagnostic and therapeutic methods, pharmaceutical compositions and reagent kits.

Prior to joining Brinks, Dr. Murray had extensive experience in the development of immunochemical test methods and medical device instrumentation, including the development of radioactive and non-radioactive immunoassay test methods, solid-phase microparticle separation techniques, automated immunoassay instrumentation and compilation of submissions to regulatory agencies. He was also the co-inventor on a number of U.S. patents.

• Leading Intellectual Property Lawyer, Leading Lawyers Network, 2011
• Illinois Super Lawyers, Rising Stars, 2008, 2009
• Journal of Intellectual Property, Illinois Institute of Technology, Chicago-Kent College of Law

• "Note: Owning Genes: Disputes Involving DNA Sequence Patents," 75 Chicago-Kent Law Review 231, 1999

• American Bar Association
• American Intellectual Property Law Association
• American Association for the Advancement of Science

• 48 Brinks Attorneys Honored as Leading Intellectual Property Lawyers for 2011
• Brinks Hofer Gilson & Lione Attorneys Sprint for Justice at Race Judicata
• Twenty-Five Brinks Hofer Gilson & Lione Attorneys Named 2009 "Illinois Super Lawyers"
• Brinks Hofer Gilson & Lione Announces New Shareholder, Counsel, Associates and Scientific Advisors

• Illinois Super Lawyers
• Chicago Magazine
• Health Law - Intellectual Property and Technology News.com
• Various Media
• Law & Politics Magazine: Illinois Super Lawyers & Rising Stars